Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.

Market volatility makes listing a ‘monumental challenge.’ Meanwhile, limited partners are under pressure as distributions dry up.

Hinge Health, a 10-year-old company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, filed ...

but that solid companies can get done and do well, which is good," said Nicholas Smith, senior research analyst at Renaissance Capital, a provider of pre-IPO research and IPO-focused ETFs.